OncoZenge AB (publ) (STO:ONCOZ)
Sweden · Delayed Price · Currency is SEK 6.17
+0.15 (2.49%)
Aug 13, 2026, 5:29 PM CET
OncoZenge AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.12 | 2.78 | 0 | 0 | 0 | - | |
Revenue Growth | -95.58% | 278300.00% | -66.67% | - | - | - |
Gross Profit | 0.12 | 2.78 | 0 | 0 | 0 | - |
Selling, General & Admin | - | - | - | - | - | 4.68 |
Research & Development | - | - | - | - | - | 0.22 |
Other Operating Expenses | 32.5 | 18.57 | 8.69 | 15.91 | 43.57 | 0 |
Total Operating Expenses | 32.5 | 18.57 | 8.69 | 15.91 | 43.57 | 4.89 |
Operating Income | -32.38 | -15.79 | -8.69 | -15.9 | -43.57 | -4.89 |
Interest Income | 0.02 | 0.02 | 0 | - | - | - |
Interest Expense | -0.5 | -0.17 | -0 | - | - | - |
Total Non-Operating Income (Expense) | -0.48 | -0.15 | -0 | - | - | - |
Pretax Income | -23.12 | -15.94 | -8.69 | -15.9 | -43.57 | -4.89 |
Provision for Income Taxes | - | - | - | - | -3.08 | 1.01 |
Net Income | -23.12 | -15.94 | -8.69 | -15.9 | -40.49 | -5.9 |
Net Income to Common | -23.12 | -15.94 | -8.69 | -15.9 | -46.65 | -3.89 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 13 | 12 | 12 | 12 | 12 | 12 |
Shares Outstanding (Diluted) | 13 | 12 | 12 | 12 | 12 | 12 |
Shares Change | 6.81% | 3.56% | - | - | - | 1852.21% |
EPS (Basic) | -1.82 | -1.31 | -0.74 | -1.36 | -3.98 | -0.33 |
EPS (Diluted) | -1.82 | -1.31 | -0.74 | -1.36 | -3.98 | -0.33 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -21.98 | -13.06 | -8.76 | -17.08 | -22.08 | -4.77 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Per Share | -1.76 | -1.08 | -0.75 | -1.46 | -1.88 | -0.41 |
Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | - | - |
Operating Margin | -18860.80% | -567.06% | -868500.00% | -530067.00% | - | - |
Profit Margin | -19263.30% | -572.56% | -868800.00% | -530067.00% | - | - |
FCF Margin | -18313.30% | -469.00% | -876400.00% | -569433.00% | - | - |
EBITDA | -22.63 | -15.79 | -8.69 | -15.9 | -20.4 | -4.89 |
EBIT | -32.38 | -15.79 | -8.69 | -15.9 | -43.57 | -4.89 |
EBIT Margin | -18860.80% | -567.06% | -868500.00% | -530067.00% | - | - |
Effective Tax Rate | - | 0.00% | 0.00% | 0.00% | 7.06% | -20.60% |